s6y
Company name or ticker
Search
BridgeBio Oncology Therapeutics, Inc.
ARS
Annual report to security holders
Filed
Tuesday, April 28, 2026
Period
Dec 31, 2025
Accession number
0001193125-26-187049
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header